Connection

Alessandro Bartoloni to Prospective Studies

Back to Details
This is a "connection" page, showing publications Alessandro Bartoloni has written about Prospective Studies.
Alessandro Bartoloni
Connection Strength
0.064
Prospective Studies
  1. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy. Int J Infect Dis. 2021 Jul; 108:231-236.
    View in: PubMed
    Score: 0.038
  2. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum Reprod. 2021 05 17; 36(6):1520-1529.
    View in: PubMed
    Score: 0.009
  3. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
    View in: PubMed
    Score: 0.009
  4. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum ß-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019 Jul; 54(1):49-54.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.